Allergy and Immunology · Orange, CA
NPI
1730115221
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8506 E Chapman Ave
Orange, CA, 92869
Phone (714) 633-4666
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
19,933 services
Medicare patients, 2024
414
Average age 72
Drug cost, 2024
$3.1M
983 prescriptions
Company payments, 2025
$135
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan E Gorenberg was code 95004 (test - miscellaneous), 6,880 times for 87 patients. In total Alan E Gorenberg billed 19,933 services in 33 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 6,880 | 87 | $3.05 | $21K |
| 95165 Treatment - Miscellaneous | Office | 5,440 | 194 | $12.28 | $67K |
| 95117 Treatment - Miscellaneous | Office | 2,883 | 200 | $9.26 | $27K |
| 95024 Test - Miscellaneous | Office | 1,574 | 72 | $6.65 | $10K |
| 95115 Treatment - Miscellaneous | Office | 632 | 48 | $7.55 | $4,774 |
| 96372 Injection Administration | Office | 438 | 40 | $10.42 | $4,562 |
| 99213 Office E&M - Established | Office | 229 | 176 | $65.44 | $15K |
| 99214 Office E&M - Established | Office | 165 | 105 | $94.80 | $16K |
| 95012 Pulmonary | Office | 144 | 124 | $15.50 | $2,232 |
| 94060 Pulmonary Function Testing | Office | 130 | 112 | $31.40 | $4,082 |
| 95180 Treatment - Miscellaneous | Office | 98 | 11 | $112.72 | $11K |
| 94729 Pulmonary Function Testing | Office | 65 | 65 | $46.80 | $3,042 |
| 94726 Pulmonary Function Testing | Office | 64 | 64 | $45.88 | $2,937 |
| 99204 Office E&M - New | Office | 52 | 52 | $126.53 | $6,579 |
| 31231 Nasal/Sinus Endoscopy | Office | 48 | 47 | $153.90 | $7,387 |
By year: 2022 $281K for 23,959 services; 2023 $230K for 19,277 services; 2024 $232K for 19,933 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan E Gorenberg prescribed most often to Medicare patients was Dupixent Syringe (Dupilumab), with 131 prescriptions and refills. In total Alan E Gorenberg wrote 983 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Syringe Dupilumab | 131 | 131 | 20 | $482K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 123 | 166 | 32 | $103K |
| Xolair Omalizumab | 103 | 107 | 14 | $330K |
| Montelukast Sodium Generic | 58 | 110 | Under 11 | $419 |
| Ipratropium Bromide Generic | 44 | 61 | 25 | $1,627 |
| Omeprazole Generic | 41 | 82 | 14 | $662 |
| Losartan Potassium Generic | 38 | 100 | 16 | $356 |
| Esomeprazole Magnesium Generic | 33 | 79 | 13 | $1,411 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 31 | 35 | Under 11 | $22K |
| Dupixent Pen Dupilumab | 30 | 30 | Under 11 | $111K |
| Famotidine Generic | 22 | 52 | Under 11 | $440 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 22 | 35 | Under 11 | $1,267 |
| Gabapentin Generic | 21 | 26 | Under 11 | $285 |
| Takhzyro Lanadelumab-Flyo | 21 | 21 | Under 11 | $1.1M |
| Spiriva Respimat Tiotropium Bromide | 16 | 18 | Under 11 | $9,374 |
Brand drugs: 548 claims; generic drugs: 435 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan E Gorenberg $135 ($135 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novartis Pharmaceuticals Corporation with $92.79.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 4 | $92.79 |
| Cycle Pharmaceuticals Inc | 1 | $22.42 |
| Azurity Pharmaceuticals, Inc. | 1 | $20.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.